高尿酸血症
尿酸
黄嘌呤氧化酶
痛风
嘌呤代谢
嘌呤
自行车
体内
次黄嘌呤
化学
黄嘌呤
生物化学
新陈代谢
体外
药理学
酶
医学
生物
生物技术
金属
有机化学
作者
Humaira Zafar,Najlae Hamdi,Mohammed Lachkar,Brahim El Bali,Ajmal Khan,Muhammad Iqbal Choudhary
出处
期刊:Medicinal Chemistry
[Bentham Science Publishers]
日期:2017-08-02
卷期号:13 (6)
被引量:3
标识
DOI:10.2174/1573406413666170309095104
摘要
Background: Uric acid is the end product of purine metabolism in humans and its increased level in serum leads to hyperuricemia. Among the different regulatory factors to control the level of uric acid in humans, xanthine oxidase (XO) is a well-established pharmacological target, as it is directly involved in uric acid production. Keywords: Dinuclear cyclam complex, xanthine oxidase inhibition, hyperuricemia, gout, uric acid, purine metabolism.
科研通智能强力驱动
Strongly Powered by AbleSci AI